ACTIVE FDA ENFORCEMENT ACTION
Warning Letter issued 2026-02-20. Status: Active. View on FDA.gov →
MEDVi
Compliance record raises significant questions worth verifying directly.
Top strengths
What stands out in MEDVi’s public record.
Worth asking about
Open questions before you commit.
What MEDVi offers
Based on publicly disclosed services and compounds.
- ·Telehealth Platform
MEDVi vs. similar providers
Peer comparison across similar telehealth platform platforms in the same space.
See the full Trust Report
The institutional version of this profile: every signal we evaluated, every federal source we checked, the six-dimension score architecture, and citation-ready evidence. Built for sharing, screenshotting, and reference.
Open Trust Report →Other telehealth platform providers
Verified telehealth platform platforms in the same category.
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.